Cumberland Pharmaceuticals Inc (CPIX)

NASD · Healthcare · Drug Manufacturers - Specialty & Generic · USA

Cumberland Pharmaceuticals Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.

Cumberland Pharmaceuticals manufactures and sells branded prescription drugs targeting hospital acute care, gastroenterology and oncology. The company operates through sales divisions in the United States and works with international partners to distribute its medicines. Its portfolio includes treatments for acetaminophen overdose, pain, fever, constipation, chemotherapy side effects and bacterial infections.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Cumberland Pharmaceuticals Inc stock.

Our verdict on CPIX

Not valued: We cannot value this company yet.

We do not publish a value for this company: not even its current assets cover what it owes.

ETFs with the most weight in CPIX

5 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Drug Manufacturers - Specialty & Generic

All 82 Drug Manufacturers - Specialty & Generic stocks

Cheaper than CPIX in Drug Manufacturers - Specialty & Generic

33 more in this industry show a wider margin of safety.

Is CPIX undervalued or overvalued?

We do not publish a verdict on CPIX yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.

What is the intrinsic value of CPIX?

We do not publish one (as of the 2026-11-17 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.